Citigroup Inc. Downgrades Eli Lilly and to Neutral

Home › Citigroup Inc. Downgrades Eli Lilly and to Neutral

They currently have a $68.00 target price on the stock, up from their previous target price of $60.00.

26.11	New swine respiratory disease treatment flexibility from nursery to finish
26.11	Panel talks capturing added value in cattle
26.11	AMS extends comment period on fed cattle market rule
26.11	When to start grazing wheat pasture?
26.11	RaboResearch: Productivity and efficiency will power the next U.S. cow herd rebuild
26.11	Study reveals vast majority of feed outages due to bin slide management mistakes
26.11	EPA releases draft farm emissions methodologies
26.11	USDA Air Quality Task Force taps two from pork industry
Agriculture and Forestry »

je.st